Skip to main content

Advertisement

Table 4 Correlation between metabolic phenotypes of tumor and clinicopathologic factors

From: Metabolic phenotypes in primary unknown metastatic carcinoma

Parameters Glycolysis type Glutaminolysis type Mitochondrial type
Yes No p-value Yes No p-value Yes No p-value
n = 33 (%) n = 44 (%)   n = 43 (%) n = 34 (%)   n = 74 (%) n = 3 (%)
Age    0.087    0.340    1.000
 <50 7 (21.2) 18 (40.9)   16 (37.2) 9 (26.5)   24 (32.4) 1 (33.3)  
 ≥50 26 (78.8) 26 (59.1)   27 (62.8) 25 (73.5)   50 (67.6) 2 (66.7)  
Sex    0.342    1.000    1.000
 Male 23 (69.7) 25 (56.8)   27 (62.8) 21 (61.8)   46 (62.2) 2 (66.7)  
 Female 10 (30.3) 19 (43.2)   16 (37.2) 13 (38.2)   28 (37.8) 1 (33.3)  
Clinical subtype    0.371    0.971    0.687
 Nodal type 18 (54.5) 16 (36.4)   18 (41.9) 16 (47.1)   33 (44.6) 1 (33.3)  
 Single organ type 5 (15.2) 10 (22.7)   9 (20.9) 6 (17.6)   15 (20.3) 0 (0.0)  
 Intermediate type 6 (18.2) 8 (18.2)   8 (18.6) 6 (17.6)   13 (17.6) 1 (33.3)  
 Carcinomatosis type 4 (12.1) 10 (22.7)   8 (18.6) 6 (17.6)   13 (17.6) 1 (33.3)  
Histologic type    0.093    0.545    0.208
 AD 11 (33.3) 16 (36.4)   17 (39.5) 10 (29.4)   26 (35.1) 1 (33.3)  
 PD 4 (12.1) 12 (27.3)   8 (18.6) 8 (23.5)   14 (18.9) 2 (66.7)  
 SQ 13 (39.4) 7 (15.9)   9 (20.9) 11 (32.4)   20 (27.0) 0 (0.0)  
 UP 5 (15.2) 9 (20.5)   9 (20.9) 5 (14.7)   14 (18.9) 0 (0.0)  
Organs involved    0.392    0.730    0.026
 Lymph node 24 (72.7) 25 (56.8)   27 (62.8) 22 (64.7)   48 (64.9) 1 (33.3)  
 Bone 3 (9.1) 7 (15.9)   7 (16.3) 3 (8.8)   10 (13.5) 0 (0.0)  
 Brain 4 (12.1) 5 (11.4)   4 (9.3) 5 (14.7)   9 (12.2) 0 (0.0)  
 Other 2 (6.1) 7 (15.9)   5 (11.6) 4 (11.8)   7 (9.5) 2 (66.7)  
  1. Bold represents p<0.05.